Φάρμακα

20 Aug

Posted at 10:18h in Φάρμακα by

Liffert Vogta, Gerjan Navisa, Ju¨ rgen Ko¨ sterb, Athanasios J. Manolisc, John L. Reidd, Dick de Zeeuwa and on behalf of the Angiotensin II Receptor Antagonist Telmisartan Micardis in Isolated Systolic Hypertension (ARAMIS) Study Group Objective: To examine the effect of telmisartan or hydrochlorothiazide on the control...

20 Aug

Posted at 10:17h in Φάρμακα by

Ralf A. Benndorf4, Tanja Rudolph, Daniel Appel, Edzard Schwedhelm, Renke Maas, Friedrich Schulze, Elisabeth Silberhorn, Rainer H. Bfger Institute of Experimental and Clinical Pharmacology and Toxicology, Department of Clinical Pharmacology, University Hospital Hamburg-Eppendorf, D-20246 Hamburg, Germany Received 18 January 2006; accepted 18 April 2006 Abstract Hypertension is a...

20 Aug

Posted at 10:16h in Φάρμακα by

A.M. Sharma1, A. Hollander2 and J. Köster3 1University Clinic Benjamin Franklin, Freie Universität, Berlin, 2Bosch Medicentrum, Den Bosch, The Netherlands, and 3Boehringer Ingelheim Pharma KG, Ingelheim, Germany, on behalf of the Efficacy and Safety in Patients with Renal Impairment treated with Telmisartan (ESPRIT) Study Group Abstract. Aims: This study as sessed the...

20 Aug

Posted at 10:14h in Φάρμακα by

Ronald Clasen, Michael Schupp, Anna Foryst-Ludwig, Christiane Sprang, Markus Clemenz, Maxim Krikov, Christa Tho¨ne-Reineke, Thomas Unger, Ulrich Kintscher Abstract The adipose-specific protein adiponectin has been recently discovered to improve insulin sensitivity. Angiotensin type-1 receptor (AT1R) blockers (ARBs) reduce the incidence of type 2 diabetes mellitus by mostly...

20 Aug

Posted at 10:13h in Φάρμακα by

Stephen C. Benson, Harrihar A. Pershadsingh, Christopher I. Ho, Amar Chittiboyina, Prashant Desai, Michal Pravenec, Nianning Qi, Jiaming Wang, Mitchell A. Avery, Theodore W. Kurtz Abstract The metabolic syndrome is a common precursor of cardiovascular disease and type 2 diabetes that is characterized by the clustering of...